Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bcl-2 family inhibitors sensitize human cancer models to therapy.
Valentini E, Di Martile M, Brignone M, Di Caprio M, Manni I, Chiappa M, Sergio I, Chiacchiarini M, Bazzichetto C, Conciatori F, D'Aguanno S, D'Angelo C, Ragno R, Russillo M, Colotti G, Marchesi F, Bellone ML, Dal Piaz F, Felli MP, Damia G, Del Bufalo D. Valentini E, et al. Cell Death Dis. 2023 Jul 17;14(7):441. doi: 10.1038/s41419-023-05963-1. Cell Death Dis. 2023. PMID: 37460459 Free PMC article.
Targeting the anti-apoptotic Bcl-2 family proteins: machine learning virtual screening and biological evaluation of new small molecules.
Valentini E, D'Aguanno S, Di Martile M, Montesano C, Ferraresi V, Patsilinakos A, Sabatino M, Antonini L, Chiacchiarini M, Valente S, Mai A, Colotti G, Ragno R, Trisciuoglio D, Del Bufalo D. Valentini E, et al. Theranostics. 2022 Feb 28;12(5):2427-2444. doi: 10.7150/thno.64233. eCollection 2022. Theranostics. 2022. PMID: 35265218 Free PMC article.
Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb.
D'Aguanno S, Valentini E, Tupone MG, Desideri M, Di Martile M, Spagnuolo M, Buglioni S, Ercolani C, Falcone I, De Dominici M, Milella M, Rizzo MG, Calabretta B, Cota C, Anichini A, Trisciuoglio D, Del Bufalo D. D'Aguanno S, et al. Among authors: valentini e. J Exp Clin Cancer Res. 2018 Nov 19;37(1):278. doi: 10.1186/s13046-018-0933-x. J Exp Clin Cancer Res. 2018. PMID: 30454024 Free PMC article.
Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages.
Di Martile M, Farini V, Consonni FM, Trisciuoglio D, Desideri M, Valentini E, D'Aguanno S, Tupone MG, Buglioni S, Ercolani C, Gallo E, Amadio B, Terrenato I, Foddai ML, Sica A, Del Bufalo D. Di Martile M, et al. Among authors: valentini e. J Immunother Cancer. 2020 Apr;8(1):e000489. doi: 10.1136/jitc-2019-000489. J Immunother Cancer. 2020. PMID: 32269145 Free PMC article.
Bcl-2-like protein-10 increases aggressive features of melanoma cells.
Del Bufalo D, Di Martile M, Valentini E, Manni I, Masi I, D'Amore A, Filippini A, Nicoletti C, Zaccarini M, Cota C, Castro MV, Quezada MJ, Rosanò L, Lopez-Bergami P, D'Aguanno S. Del Bufalo D, et al. Among authors: valentini e. Explor Target Antitumor Ther. 2022;3(1):11-26. doi: 10.37349/etat.2022.00068. Epub 2022 Jan 30. Explor Target Antitumor Ther. 2022. PMID: 36046354 Free PMC article.
microRNA-378a-5p iS a novel positive regulator of melanoma progression.
Tupone MG, D'Aguanno S, Di Martile M, Valentini E, Desideri M, Trisciuoglio D, Donzelli S, Sacconi A, Buglioni S, Ercolani C, Biagioni A, Fibbi G, Fattore L, Mancini R, Ciliberto G, Blandino G, Del Bufalo D. Tupone MG, et al. Among authors: valentini e. Oncogenesis. 2020 Feb 14;9(2):22. doi: 10.1038/s41389-020-0203-6. Oncogenesis. 2020. PMID: 32060259 Free PMC article.
Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cells.
Di Martile M, Gabellini C, Desideri M, Matraxia M, Farini V, Valentini E, Carradori S, Ercolani C, Buglioni S, Secci D, Andreazzoli M, Del Bufalo D, Trisciuoglio D. Di Martile M, et al. Among authors: valentini e. J Exp Clin Cancer Res. 2020 Jun 5;39(1):103. doi: 10.1186/s13046-020-01604-z. J Exp Clin Cancer Res. 2020. PMID: 32498717 Free PMC article.
150 results